Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

First Dupuytren's contracture jab

  • Comment

People with Dupuytren’s contracture will now be able to avoid surgery to correct the condition.

The condition causes fingers to pull permanently towards the palm and makes everyday tasks, such as dressing and washing, very difficult. Sufferers are also likely to suffer wider psychological effects.

Dupuytren’s contracture is commonly treated with surgery, but this has been linked to post-operative complications, high rates of recurrence and disruption to patients’ lives.

Pfizer has developed Xiapex, which is the first injection available to treat the condition. Just 24 hours after the injection, a procedure can be carried out to help straighten the patient’s finger.

Jonathan Jones, medical director of Pfizer’s Speciality Care Business Unit, said: “The development and availability of a new treatment like Xiapex for Dupuytren’s contracture demonstrates Pfizer’s continued commitment to bring new innovative medicines to patients and is good news for patients and physicians alike.”

Sign our petition today to ensure nurses have a seat on consortia boards! Follow @Aseatontheboard on twitter follow for all the latest campaign news!

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.